PAM
RIGL icon

Panagora Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Panagora Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,132
Closed -$200K – 1434
2023
Q1 		$200K Sell
15,132
-67,251
-82% -$1.07M ﹤0.01% 1381
2022
Q4 		$1.24M Buy
82,383
+18,914
+30% +$173K 0.01% 805
2022
Q3 		$749K Buy
63,469
+10,446
+20% +$141K 0.01% 978
2022
Q2 		$599K Buy
53,023
+5,563
+12% +$112K ﹤0.01% 1096
2022
Q1 		$1.42M Buy
47,460
+2,259
+5% +$61.2K 0.01% 801
2021
Q4 		$1.2M Sell
45,201
-377
-0.8% -$11.4K 0.01% 834
2021
Q3 		$1.65M Sell
45,578
-16,528
-27% -$651K 0.01% 762
2021
Q2 		$2.69M Sell
62,106
-59,839
-49% -$2.26M 0.01% 618
2021
Q1 		$4.17M Buy
121,945
+16,467
+16% +$652K 0.02% 518
2020
Q4 		$3.69M Buy
105,478
+2,251
+2% +$65.2K 0.02% 502
2020
Q3 		$2.48M Buy
103,227
+7,378
+8% +$181K 0.02% 561
2020
Q2 		$1.75M Buy
95,849
+5,535
+6% +$99.6K 0.01% 719
2020
Q1 		$1.41M Sell
90,314
-15,964
-15% -$340K 0.01% 717
2019
Q4 		$2.27M Buy
106,278
+57,270
+117% +$1.18M 0.01% 734
2019
Q3 		$916K Buy
49,008
+48,560
+10,839% +$1M ﹤0.01% 1052
2019
Q2 		$12K Buy
+448
New +$10.1K ﹤0.01% 2374
2017
Q1 		– Sell
-14,958
Closed -$356K – 2440
2016
Q4 		$356K Sell
14,958
-412
-3% -$11.8K ﹤0.01% 1564
2016
Q3 		$564K Buy
15,370
+519
+3% +$14.9K ﹤0.01% 1405
2016
Q2 		$331K Buy
14,851
+2,092
+16% +$52K ﹤0.01% 1492
2016
Q1 		$265K Buy
12,759
+1,223
+11% +$30.2K ﹤0.01% 1565
2015
Q4 		$349K Buy
11,536
+2,254
+24% +$68.3K ﹤0.01% 1437
2015
Q3 		$229K Buy
9,282
+8,039
+647% +$240K ﹤0.01% 1564
2015
Q2 		$40K Buy
+1,243
New +$47.5K ﹤0.01% 2193

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Panagora Asset Management's RIGL Position: Q2 2023 in Review

Panagora Asset Management sold out of Rigel Pharmaceuticals (RIGL) in Q2 2023, closing a stake of 15,132 shares — an estimated $200K sold.

Panagora Asset Management first reported a position in RIGL in Q2 2015 and held it in 23 quarters. The position peaked at $4.17M in Q1 2021. 118 funds tracked by Wall St. Rank hold RIGL as of Q2 2023.

  • Panagora Asset Management reported no remaining Rigel Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Panagora Asset Management sold 15,132 Rigel Pharmaceuticals shares in Q2 2023, an estimated $200K.
  • Panagora Asset Management first reported a position in Rigel Pharmaceuticals in Q2 2015 and held it in 23 quarters.
  • Panagora Asset Management's Rigel Pharmaceuticals position peaked at $4.17M in Q1 2021.
  • 118 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2023.

Based on Panagora Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.